- Home
- ETD vs AUTL Comparison
ETD vs AUTL Comparison
Compare ETD & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETD
- AUTL
- Stock Information
- Founded
- ETD 1932
- AUTL 2014
- Country
- ETD United States
- AUTL United Kingdom
- Employees
- ETD N/A
- AUTL N/A
- Industry
- ETD Home Furnishings
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ETD Consumer Discretionary
- AUTL Health Care
- Exchange
- ETD Nasdaq
- AUTL Nasdaq
- Market Cap
- ETD 709.8M
- AUTL 590.8M
- IPO Year
- ETD 1993
- AUTL 2018
- Fundamental
- Price
- ETD $27.70
- AUTL $1.55
- Analyst Decision
- ETD Hold
- AUTL Strong Buy
- Analyst Count
- ETD 2
- AUTL 4
- Target Price
- ETD $32.00
- AUTL $9.15
- AVG Volume (30 Days)
- ETD 293.9K
- AUTL 1.3M
- Earning Date
- ETD 04-23-2025
- AUTL 03-20-2025
- Dividend Yield
- ETD 5.61%
- AUTL N/A
- EPS Growth
- ETD N/A
- AUTL N/A
- EPS
- ETD 2.39
- AUTL N/A
- Revenue
- ETD $626,650,000.00
- AUTL $10,120,000.00
- Revenue This Year
- ETD N/A
- AUTL $274.71
- Revenue Next Year
- ETD $2.47
- AUTL $239.55
- P/E Ratio
- ETD $11.52
- AUTL N/A
- Revenue Growth
- ETD N/A
- AUTL 496.00
- 52 Week Low
- ETD $26.13
- AUTL $1.52
- 52 Week High
- ETD $35.62
- AUTL $6.31
- Technical
- Relative Strength Index (RSI)
- ETD 48.01
- AUTL 33.58
- Support Level
- ETD $27.54
- AUTL $1.58
- Resistance Level
- ETD $28.16
- AUTL $1.70
- Average True Range (ATR)
- ETD 0.77
- AUTL 0.13
- MACD
- ETD 0.11
- AUTL -0.02
- Stochastic Oscillator
- ETD 62.06
- AUTL 6.06
About ETD Ethan Allen Interiors Inc.
Ethan Allen Interiors Inc through its subsidiaries, operates as an interior design company, and a manufacturer and retailer in the home furnishings marketplace. Its product offerings include fabric chairs, beds, wallpapers, desks, and dining tables among others. The company's reportable segments are; Wholesale and Retail. The Wholesale segment is principally involved in the development of the Ethan Allen brand and encompasses all aspects of design, manufacturing, sourcing, marketing, sale, and distribution of home furnishings and accents. The Retail segment which generates maximum revenue, sells home furnishings and accents to clients through company-operated design centers. Geographically, it derives key revenue from the United States and the rest from other regions.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.